If you've read anything about ADHD brain screening, you've encountered the term "theta/beta ratio." It appears in research papers, screening reports, and clinical guidelines. It was referenced by the FDA. It has been the subject of over 30 years of published research.
But what actually is it? What does it measure? Why does it matter? And what does your number mean?
This article explains the theta/beta ratio from the ground up — no neuroscience degree required. By the end, you'll understand the single most important number in an ADHD brain screening report.
What is the theta/beta ratio?
Your brain produces electrical activity continuously. This activity oscillates at different frequencies — some slow, some fast — and neuroscientists have divided the spectrum into named bands. Two of these bands are central to ADHD:
Theta (4-8 Hz) — slow waves associated with daydreaming, internal processing, and unfocused mental states. When your mind wanders during a meeting, your brain is producing theta. When a child stares out the window during a maths lesson, their cortex is dominated by theta. It's not a disorder in itself — everyone produces theta. But in ADHD, there is too much of it when the situation calls for focus.
Beta (12-30 Hz) — fast waves associated with active concentration, problem-solving, and engaged attention. When you're deeply focused on a task, your brain is producing beta. When a student is locked in during an exam, beta is dominant. This is the brain state that ADHD brains struggle to generate and maintain.
The theta/beta ratio is simply the relationship between these two: how much theta your brain produces compared to how much beta. A higher ratio means more daydreaming activity relative to concentration activity. A lower ratio means the opposite.
The formula: theta ÷ beta
4-8 Hz
12-30 Hz
The measurement is taken at Cz — the central vertex of the scalp, directly over the sensorimotor cortex. This is the standardised measurement site used in the majority of ADHD TBR research and the site specified in the FDA's clearance of the NEBA System. A secondary measurement is taken at Fz (frontal midline), which provides additional data about prefrontal cortical function.
The raw ratio number itself isn't clinically meaningful without context — a TBR of 4.0 means something different for a 7-year-old than for a 40-year-old. This is why results are expressed as z-scores against age-matched published norms. The z-score tells you how your ratio compares to people of the same developmental stage.
Why does it matter for ADHD?
The theta/beta ratio matters because it captures the core neurological mechanism of ADHD: cortical hypoarousal.
The ADHD brain is not broken. It is not damaged. It is not deficient in some absolute sense. It is under-aroused. The neural circuits responsible for sustained attention, working memory, and executive function are not generating enough activation to work at full capacity. The cortex sits in a state that is shifted toward theta (unfocused) and away from beta (focused).
This explains the entire symptom profile of ADHD. Difficulty sustaining attention? The cortex isn't producing enough beta to maintain focus. Hyperfocus on interesting tasks? Interesting stimuli generate dopamine, which temporarily boosts cortical arousal and normalises the ratio. Stimulant medication helps? Stimulants increase cortical arousal — they boost beta and suppress theta, moving the ratio toward normal.
The TBR is not a peripheral marker that happens to correlate with ADHD. It is a direct measurement of the neurological state that causes the symptoms. That's why it has survived 30 years of scientific scrutiny — it measures the mechanism, not just its consequences.
This is why ADHD children seem "wired" despite being neurologically under-aroused. The brain is seeking stimulation to compensate for its low arousal state. Fidgeting, talking, bouncing, risk-taking — these are all self-stimulation strategies that the brain uses to generate the arousal it isn't producing internally. The behaviour looks like excess energy. The neurology shows deficit energy. The TBR reveals the truth behind the paradox.
30 years of research
The theta/beta ratio didn't appear overnight. It is the product of three decades of cumulative research across multiple countries, laboratories, and clinical populations.
The discovery
Early researchers including Lubar, Monastra, and others observe that children with attention disorders consistently show elevated theta relative to beta in EEG recordings. The pattern is replicated across multiple labs. The theta/beta ratio is proposed as a quantitative biomarker for ADHD.
Monastra establishes normative data
Monastra et al. publish landmark studies establishing TBR norms across age groups. Their work provides the first large-scale normative database against which individual results can be compared. These norms remain foundational to qEEG ADHD assessment today.
Clarke confirms across populations
Clarke et al. replicate the elevated TBR finding in Australian cohorts, establishing that the biomarker is not culturally or geographically specific. The pattern holds across populations — it is a neurological constant, not an environmental artefact.
FDA clears the NEBA System
The US Food and Drug Administration clears the NEBA System as a diagnostic aid for ADHD in children aged 6-17. The clearance is based on theta/beta ratio measurement at Cz. This is the first brain-wave device cleared for clinical use in ADHD evaluation.
Arns meta-analysis and Snyder replication
Arns et al. publish a comprehensive meta-analysis examining TBR across hundreds of studies. Snyder et al. provide additional normative data. The evidence base grows to include over 300 subjects across multiple age groups, strengthening the statistical foundation of TBR-based screening.
Clinical adoption
TBR-based screening enters mainstream clinical practice in the UK, US, and Europe. Professional organisations including ISNR and AAPB recognise qEEG assessment as Level 1 (Best Practice) for ADHD evaluation. The biomarker transitions from research curiosity to clinical tool.
The FDA clearance
In July 2013, the US Food and Drug Administration cleared the NEBA System — a device that measures the theta/beta ratio at Cz to aid in the evaluation of ADHD in patients aged 6-17. The clearance was based on a multi-site clinical trial demonstrating that TBR data, combined with standard clinical evaluation, improved diagnostic accuracy.
This was significant for two reasons. First, it was the first brain-wave device ever cleared by the FDA for clinical use in ADHD evaluation. Second, it validated the theta/beta ratio as a measurement worth incorporating into clinical practice — not as a replacement for clinical judgment, but as an objective data point that makes clinical judgment more accurate.
Our screening measures the same biomarker, at the same electrode site (Cz), using the same analytical approach. The FDA clearance applies specifically to the NEBA System device, not to qEEG in general — but the underlying science is identical. The theta/beta ratio doesn't change because you measure it with a different brand of electrode.
Why age matters
The brain matures throughout childhood and adolescence. One of the most consistent features of this maturation is a gradual decrease in theta activity and a corresponding increase in beta activity. In other words, the theta/beta ratio naturally decreases with age.
This is why a raw TBR number is meaningless without age context. A ratio of 4.5 might be perfectly normal for a 7-year-old but significantly elevated for a 35-year-old. This is also why questionnaire-only assessment is problematic for younger children — the natural high-theta state of a young brain makes it harder to distinguish normal developmental theta from ADHD-pattern excess theta using behavioural observation alone.
Our normative database includes age-matched data from published research covering 10 age groups from 6-7 through to 60+. When we calculate your z-score, we compare your TBR against the published mean for your specific age bracket — ensuring the comparison is developmentally appropriate.
Our normative database
The strength of any TBR measurement depends entirely on the quality of the normative data it's compared against. Our database is built from six peer-reviewed research sources:
Foundational ADHD TBR norms
Established the first comprehensive normative database for theta/beta ratio across child and adolescent age groups. The most widely cited TBR reference in ADHD research.
Cross-population replication
Replicated elevated TBR findings in Australian cohorts, confirming the biomarker is consistent across populations and not culturally specific.
Meta-analysis and adult norms
Comprehensive meta-analysis examining TBR across the full research literature. Extended normative data into adult age groups previously underrepresented.
Additional normative subjects
Contributed further normative data strengthening the statistical foundation across age groups and increasing total reference subjects.
European normative data
Extended the normative database with European cohort data, ensuring international applicability of TBR reference values.
311+ subjects across 10 age groups
Our composite database draws from all six sources, covering ages 6-7 through to 60+. Every z-score in your report references this published, peer-reviewed data.
This matters because it means your result isn't being compared against a proprietary, unpublished database that you have no way to verify. Every reference value in our system comes from publicly available, peer-reviewed research that any clinician can independently examine.
What your screening report actually shows
When you receive your same-day screening report, the theta/beta ratio is the headline number — but it sits within a broader picture of brain data. Understanding each component helps you and your clinician get the most from the results.
Theta/beta ratio with z-score: This is the primary ADHD-relevant measurement. The z-score tells you how many standard deviations your TBR falls from the age-matched normative mean. A z-score of 0 means you’re exactly average. Below 1.5 is within normal range. Between 1.5 and 2.0 is elevated (warrants clinical investigation). Above 2.0 is clinically significant (strongly consistent with ADHD neurology).
Full frequency analysis: Your report includes power values across the entire EEG spectrum — delta (1-4 Hz), theta (4-8 Hz), alpha (8-12 Hz), beta (12-30 Hz), and high beta (30-40 Hz). This reveals more than just the TBR. Elevated alpha alongside elevated theta may indicate anxiety comorbidity. Elevated high beta can suggest hyperarousal or medication effects. The full spectrum gives your clinician a complete picture of cortical activity.
Go/No-Go attention task results: During your screening, you complete a three-minute sustained attention task requiring you to respond to target stimuli and inhibit responses to non-targets. The results quantify four key metrics: sustained attention (can you maintain focus over three minutes?), impulse control (can you stop yourself responding to non-targets?), response consistency (how variable are your reaction times?), and processing speed (how quickly do you respond to targets?). These behavioural metrics complement the neurological data — they show what brain activity looks like in action, not just at rest.
Topographic mapping: Your report may include topographic head maps showing the distribution of activity across different brain regions. This helps identify whether the pattern is localised to frontal regions (common in inattentive ADHD) or more widespread (common in combined type).
All of this data is presented in a professional PDF designed to be shared with your GP, psychiatrist, school SENCO, or employer. The comprehensive package (£845) adds a clinical interpretation letter translating the data into plain-language clinical context.
TBR and other conditions
One of the most clinically valuable aspects of the theta/beta ratio is its role in differential diagnosis — helping distinguish ADHD from conditions with overlapping symptoms.
Anxiety: Anxiety often produces elevated beta (the brain is hypervigilant and over-aroused) rather than the reduced beta seen in ADHD. A person with anxiety may report difficulty concentrating, but their EEG shows high beta and normal or low theta — the opposite of the ADHD pattern. If your TBR is normal but beta is elevated, this points toward anxiety rather than ADHD.
Depression: Depression can produce elevated theta, similar to ADHD, but typically with elevated alpha as well — a pattern of cortical disengagement rather than hypoarousal. Depression-related attention difficulties tend to emerge with the depressive episode and resolve when mood improves, whereas ADHD-related patterns are lifelong.
Sleep disorders: Poor sleep elevates theta activity and can mimic ADHD symptoms almost perfectly. This is why our preparation guidelines ask about sleep quality before your recording. A TBR elevated in someone with chronic insomnia needs cautious interpretation — clinical context is essential.
ADHD + anxiety comorbidity: Many people have both. The EEG can show this: elevated theta and elevated beta simultaneously, suggesting cortical hypoarousal (ADHD) combined with compensatory hypervigilance (anxiety). This is particularly common in women with ADHD who have spent years anxiously compensating for their attention difficulties.
TBR and medication
One of the most clinically valuable aspects of the theta/beta ratio is that it responds to treatment. Stimulant medications — methylphenidate (Ritalin, Concerta) and amphetamine-based medications (Elvanse, Dexamfetamine) — work by increasing cortical arousal. On an EEG, this manifests as reduced theta and increased beta, moving the TBR toward the normative range.
This creates a powerful clinical tool: the medication comparison scan. A baseline TBR is established before medication, then a follow-up measurement is taken after medication has reached steady state. If the TBR has decreased toward the normative mean, the medication is having the intended neurological effect. If it hasn't changed, the medication may not be working at that dose or type — information that is otherwise only available through subjective self-report.
Asking a patient "is your medication working?" is like asking someone with high blood pressure "do you feel less pressured?" The answer may or may not correlate with reality. Measuring the TBR before and after medication is like checking blood pressure before and after — it tells you whether the underlying physiology has actually changed. That's evidence-based medication management.
What the ratio can't tell you
The theta/beta ratio is powerful, well-researched, and clinically meaningful. It is also not perfect, and scientific honesty requires acknowledging its limitations:
It is not diagnostic alone. An elevated TBR is consistent with ADHD but not exclusive to it. Other conditions — including some sleep disorders, depression, and traumatic brain injury — can also produce elevated theta. Clinical context is essential. This is why we emphasise that our screening is supporting evidence for clinical evaluation, not a standalone diagnosis.
Not every person with ADHD has an elevated TBR. Research suggests that approximately 60-70% of individuals with clinically diagnosed ADHD show elevated TBR. The remaining 30-40% may have ADHD through different neurological mechanisms that don't manifest as a theta/beta ratio abnormality. A normal TBR does not rule out ADHD — it means that this particular biomarker is not elevated.
The ratio is a snapshot. It captures brain activity at a single point in time. Fatigue, caffeine, sleep quality, and anxiety can all influence the recording. This is why we control for these factors in our preparation guidelines and why repeated measurement can strengthen confidence in the findings.
These limitations are real but they don't diminish the value of the measurement. A blood pressure reading is also a snapshot, also influenced by context, and also not diagnostic alone. It is still one of the most useful clinical measurements in medicine. The TBR occupies a similar position for ADHD — not the whole answer, but a critically important piece of objective data.
Research from the American Academy of Neurology found that combining TBR data with standard clinical evaluation improves ADHD diagnostic accuracy to 89-94% — significantly higher than either approach alone. The brain data provides what the interview cannot (objective measurement), and the interview provides what brain data cannot (developmental history, functional context). Together, they produce the most accurate assessment available. Our comprehensive assessment combines both in a single appointment.
Common questions
Find out your theta/beta ratio
30 minutes. Four electrodes. Your number compared against 311 research subjects. Same-day report.
Book your screening →Related: The full science · What a brain scan shows · ADHD or anxiety? · Results explained · Medication comparison scan